Enhanced production of recombinant calf chymosin in Kluyveromyces lactis via CRISPR-Cas9 engineering

被引:0
|
作者
Zheng, Yanli [1 ]
Wang, Shiqing [1 ]
Deng, Yuhui [1 ]
Hu, Ping [1 ,2 ]
Xue, Qingxin [3 ]
Li, Jiaxin [3 ]
Lei, Lei [1 ]
Chan, Zhuhua [2 ]
Yang, Jiangke [1 ]
Peng, Wenfang [3 ]
机构
[1] Wuhan Polytech Univ, Coll Life Sci & Technol, Wuhan 430023, Peoples R China
[2] Marine Biol Resources Dev & Utilizat Engn Technol, TIO, MNR, Xiamen 361005, Fujian, Peoples R China
[3] Hubei Univ, Hubei Engn Res Ctr Bioenzyme Catalysis, Environm Microbial Technol Ctr Hubei Prov, Sch Life Sci,State Key Lab Biocatalysis & Enzyme E, Wuhan 430062, Peoples R China
关键词
Kluyveromyces lactis; Precision strain engineering; CRISPR-Cas9; Recombinant calf chymosin; Secretory production; High-yield and industrial-scale; KLPMR1; GENE; EXPRESSION; SECRETION; GENOME; INACTIVATION; PROTEINS; TOOL;
D O I
10.1016/j.biortech.2025.132116
中图分类号
S2 [农业工程];
学科分类号
0828 ;
摘要
As an important industrial enzyme, chymosin has been widely used in cheese manufacturing. Fermentation with Kluyveromyces lactis has allowed recombinant chymosin production to fit the growing global demand for cheese consumption; yet improvements can be made to allow for stable and larger-scale production. In this work, various chymosin producing (CP) strains were constructed via targeted chromosomal integration of various copies of a prochymosin expression cassette (PEC) using a CRISPR-Cas9 platform optimized for K. lactis. It enabled the demonstration that chymosin yields could be increased along with gradual chromosomal accumulation of PEC inserts within up to 3 copies. Finally, an optimal CP3i strain was constructed, and with which high yields of recombinant chymosin were attained, reaching ca. 1,200 SU/mL in shake-flask fermentation and ca. 28,000 SU/mL in batch-mode bioreaction, respectively. The activity of the product in milk-curding was observed. These findings provide direction to apply K. lactis-based platforms in the subsequent industrial-scale production of recombinant chymosin.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] CRISPR/Cas9-Based Genome Editing for Protein Expression and Secretion in Kluyveromyces lactis
    Liao, Lingtong
    Shen, Xiuru
    Shen, Zhiyu
    Du, Guocheng
    Li, Jianghua
    Zhang, Guoqiang
    ACS SYNTHETIC BIOLOGY, 2024, 13 (07): : 2105 - 2114
  • [42] CRISPR-Cas9 Direct Fusions for Improved Genome Editing via Enhanced Homologous Recombination
    Tabassum, Tahmina
    Pietrogrande, Giovanni
    Healy, Michael
    Wolvetang, Ernst J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [43] Advances in engineering CRISPR-Cas9 as a molecular Swiss Army knife
    Meaker, Grace A.
    Hair, Emma J.
    Gorochowski, Thomas E.
    SYNTHETIC BIOLOGY, 2020, 5 (01)
  • [44] Genome engineering of Clostridium difficile using the CRISPR-Cas9 system
    Wang, S.
    Hong, W.
    Dong, S.
    Zhang, Z. -T.
    Zhang, J.
    Wang, L.
    Wang, Y.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (10) : 1095 - 1099
  • [45] CRISPR-Cas9 In Situ engineering of subtilisin E in Bacillus subtilis
    Price, Marcus A.
    Cruz, Rita
    Baxter, Scott
    Escalettes, Franck
    Rosser, Susan J.
    PLOS ONE, 2019, 14 (01):
  • [46] Engineering designer beta cells with a CRISPR-Cas9 conjugation platform
    Donghyun Lim
    Vedagopuram Sreekanth
    Kurt J. Cox
    Benjamin K. Law
    Bridget K. Wagner
    Jeffrey M. Karp
    Amit Choudhary
    Nature Communications, 11
  • [47] CRISPR-Cas9 genome engineering: Treating inherited retinal degeneration
    Burnight, Erin R.
    Giacalone, Joseph C.
    Cooke, Jessica A.
    Thompson, Jessica R.
    Bohrer, Laura R.
    Chirco, Kathleen R.
    Drack, Arlene V.
    Fingert, John H.
    Worthington, Kristan S.
    Wiley, Luke A.
    Mullins, Robert F.
    Stone, Edwin M.
    Tucker, Budd A.
    PROGRESS IN RETINAL AND EYE RESEARCH, 2018, 65 : 28 - 49
  • [48] A variant CRISPR-Cas9 system adds versatility to genome engineering
    Walsh, Ryan M.
    Hochedlinger, Konrad
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (39) : 15514 - 15515
  • [49] Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch
    Oakes, Benjamin L.
    Nadler, Dana C.
    Flamholz, Avi
    Fellmann, Christof
    Staahl, Brett T.
    Doudna, Jennifer A.
    Savage, David F.
    NATURE BIOTECHNOLOGY, 2016, 34 (06) : 646 - 651
  • [50] CRISPR-Cas9 engineering and screening in primary human T cells
    Ghirelli, Cristina
    Laurent, Thibault
    Hoenderdos, Kim
    Lowe, Chris
    McCarthy, Nicola
    Moore, Jonathan
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)